Annexin A1 in the nervous and ocular systems

被引:5
|
作者
Wang, Aijia [1 ]
Zhang, Hong [1 ]
Li, Xing [2 ]
Zhao, Yin [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Annexin A1 (ANXA1); glaucoma; nervous system; neuroprotection; neuroregeneration; ocular disease; retina; ISCHEMIA-REPERFUSION INJURY; NUCLEAR TRANSLOCATION; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL EXPRESSION; GENE-THERAPY; SPINAL-CORD; IN-VIVO; BRAIN; PEPTIDE; INHIBITION;
D O I
10.4103/1673-5374.380882
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The therapeutic potential of Annexin A1, an important member of the Annexin superfamily, has become evident in results of experiments with multiple human systems and animal models. The anti-inflammatory and pro-resolving effects of Annexin A1 are characteristic of pathologies involving the nervous system. In this review, we initially describe the expression sites of Annexin A1, then outline the mechanisms by which Annexin A1 maintains the neurological homeostasis through either formyl peptide receptor 2 or other molecular approaches; and, finally, we discuss the neuroregenerative potential qualities of Annexin A1. The eye and the nervous system are anatomically and functionally connected, but the association between visual system pathogenesis, especially in the retina, and Annexin A1 alterations has not been well summarized. Therefore, we explain the beneficial effects of Annexin A1 for ocular diseases, especially for retinal diseases and glaucoma on the basis of published findings, and we explore present and future delivery strategies for Annexin A1 to the retina.
引用
收藏
页码:591 / 597
页数:7
相关论文
共 50 条
  • [1] Annexin A1 in the nervous and ocular systems
    Aijia Wang
    Hong Zhang
    Xing Li
    Yin Zhao
    Neural Regeneration Research, 2024, 19 (03) : 591 - 597
  • [2] Effects of hyperosmolarity on annexin A1 on ocular surface epithelium in vitro
    Angel Fernandez-Torres, Miguel
    Eugenia Lledo, Victoria
    Perez de Lara, Maria J.
    Guzman-Aranguez, Ana
    EXPERIMENTAL EYE RESEARCH, 2022, 224
  • [3] The involvement of anti-inflammatory protein, Annexin A1, in ocular toxoplasmosis
    Mimura, Kallyne K.
    Tedesco, Roberto C.
    Calabrese, Katia S.
    Gil, Cristiane D.
    Oliani, Sonia M.
    MOLECULAR VISION, 2012, 18 (163-64): : 1583 - 1593
  • [4] Expression of Annexin A1 and UCH-L1 in central nervous system neuroepithelial tumors
    Takaew, Kanokkarn
    Wongphoom, Jutamas
    Ruangvejvorachai, Preecha
    Shuangshoti, Shanop
    ASIAN BIOMEDICINE, 2013, 7 (01) : 81 - 88
  • [5] Annexin V, Annexin A1 and cardiovascular risk in HIVpopulation
    Ucciferri, C.
    Falasca, K.
    Auricchio, A.
    Vignale, F.
    Reale, M.
    D'Angelo, C.
    Lombardi, F.
    Belmonti, S.
    Ciccullo, A.
    Baldin, G.
    Giambenedetto, S.
    Vecchiet, J.
    HIV MEDICINE, 2019, 20 : 149 - 149
  • [6] ANNEXIN A1 AND PPARγ ON RESOLUTION OF INFLAMMATION
    Farsky, S. H. P.
    Santin, J. R.
    Takahama, C.
    Machado, I. D.
    Teixeira, S.
    Muscara, M. N.
    Pitta, I. R.
    Solito, E.
    Perretti, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 286 - 286
  • [7] Advancements of Annexin A1 in inflammation and tumorigenesis
    Shao, Gang
    Zhou, Hanwei
    Zhang, Qiyu
    Jin, Yuanting
    Fu, Caiyun
    ONCOTARGETS AND THERAPY, 2019, 12 : 3245 - 3254
  • [8] Annexin A1 and leukemia: A systematic review
    Hatah, Ernieda
    Hui, Phylicia Gan Yin
    Kumolosasi, Endang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (12) : 2653 - 2668
  • [9] The complex understanding of Annexin A1 phosphorylation
    D'Acunto, Cosimo Walter
    Gbelcova, Helena
    Festa, Michela
    Ruml, Tomas
    CELLULAR SIGNALLING, 2014, 26 (01) : 173 - 178
  • [10] Contribution of annexin A1 to anticancer immunosurveillance
    Baracco, Elisa Elena
    Stoll, Gautier
    Van Endert, Peter
    Zitvogel, Laurence
    Vacchelli, Erika
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2019, 8 (11):